Refine
Has Fulltext
- yes (8)
Is part of the Bibliography
- yes (8)
Document Type
- Journal article (8)
Language
- English (8)
Keywords
- Parkinson's disease (3)
- deep brain stimulation (3)
- subthalamic nucleus (3)
- vestibular schwannoma (3)
- Parkinson’s disease (2)
- local field potentials (2)
- ADAM9 (1)
- CXCR4 (1)
- DBS biomarkers (1)
- DBS programming (1)
- Merlin (1)
- PET/CT (1)
- Pentixafor (1)
- acoustic neuroma (1)
- auditory brainstem implant (1)
- beta oscillations (1)
- beta power (1)
- chronic stimulation (1)
- coherence analysis (1)
- directional deep brain stimulation (1)
- dopamine (1)
- image-guided programming (1)
- imaging (1)
- immunofuorescence double staining (1)
- integrin (1)
- knock down (1)
- molecular imaging (1)
- motor control (1)
- movement (1)
- movement disorders (1)
- nonauditory side effects (1)
- open-set sentence recognition (1)
- pathogenesis (1)
- primary cell culture (1)
- randomized controlled double-blind study (1)
- subjective benefits (1)
Objectives: Deep brain stimulation (DBS) programming is based on clinical response testing. Our clinical pilot trial assessed the feasibility of image-guided programing using software depicting the lead location in a patient-specific anatomical model.
Methods: Parkinson's disease patients with subthalamic nucleus-DBS were randomly assigned to standard clinical-based programming (CBP) or anatomical-based (imaging-guided) programming (ABP) in an 8-week crossover trial. Programming characteristics and clinical outcomes were evaluated.
Results: In 10 patients, both programs led to similar motor symptom control (MDS-UPDRS III) after 4 weeks (medicationOFF/stimulationON; CPB: 18.27 ± 9.23; ABP: 18.37 ± 6.66). Stimulation settings were not significantly different, apart from higher frequency in the baseline program than CBP (p = 0.01) or ABP (p = 0.003). Time spent in a program was not significantly different (CBP: 86.1 ± 29.82%, ABP: 88.6 ± 29.0%). Programing time was significantly shorter (p = 0.039) with ABP (19.78 ± 5.86 min) than CBP (45.22 ± 18.32).
Conclusion: Image-guided DBS programming in PD patients drastically reduces programming time without compromising symptom control and patient satisfaction in this small feasibility trial.